Patients could get NHS medicines months earlier under fast-track pilots The Department of Health and Social Care said the pilots will test new approaches to medicines pricing, access and adoption as early as September 2026.…
Health news round-up: public health, cardiovascular risk and take-up of new medicines on the NHS Our weekly summary of important developments in pharmacy and health news you may have missed.…
Drug–food interactions: pharmacological principles and management strategies A summary of the underlying pharmacological principles for common drug–food interactions, outlining practical management strategies that can be used with patients in clinical practice.…
Prescribing unlicensed and off-label medicines An overview of how to safely and effectively prescribe unlicensed and off-label medicines through governance principles and important pharmaceutical quality considerations.…
NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Barcode errors ‘potentially fatal’, warns patient safety commissioner Exclusive: All four UK chief pharmaceutical officers also wrote an open letter to pharmaceutical companies earlier this year urging them to continue 2D barcodes on medicine packs, despite it no longer being mandatory following Brexit.…
How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
An increased focus on calculation competency as a regulatory requirement has never been more critical A senior lecturer in pharmacy at Kingston University discusses the importance of pharmacy students being able to demonstrate calculations competence before joining the General Pharmaceutical Council prescriber register.…
Vigilance needed for posaconazole product mis-selection A new safety concern has emerged in UK pharmacy practice following launch of the gastro-resistant posaconazole powder for oral suspension (Noxafil 300 mg gastro-resistant powder and solvent for oral suspension; Merck Sharp and Dohme). This product, now licensed for paediatric patients from the age o…
Combination inhaler therapy cuts asthma attacks in children by almost half Study results revealed that the annualised rate of asthma attacks was lower in participants who used a budesonide-formoterol inhaler compared with participants who used a short-acting β2-agonist inhaler.…
